PTC Therapeutics Announces Sepiapterin NDA Submission to FDA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 64.70 +2.14 (3.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.56 | 52 Week High | $35.40 | |||
| Open | $62.52 | 52 Week Low | $4.03 | |||
| Day High | $64.73 | P/E | 6.88 | |||
| Day Low | $62.20 | EPS | $9.40 | |||
| Volume | 1,163,695 | |||||
